Alzamend Neuro (ALZN) EPS (Diluted) (2021 - 2026)
Alzamend Neuro (ALZN) recorded EPS (Diluted) of $0.67 in fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$1.28 a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) EPS (Diluted) (2021 - 2026) Analysis & Trends
On a TTM basis, Alzamend Neuro's EPS (Diluted) came in at -$0.69 as of Jul 31, 2026; for FY2026 (ended Apr 30, 2026), it was -$2.63.
- Across earlier fiscal years, EPS (Diluted) came in at -$11.32 in FY2025, -$132.33 in FY2024, -$205.97 in FY2023 and -$187.31 in FY2022.
- The fiscal Q1 2027 figure is the highest quarterly EPS (Diluted) in data going back to fiscal Q1 2022.
- Per Business Quant, the preceding three fiscal quarters came in at -$0.86 (Q4 2026), -$0.58 (Q3 2026) and -$0.30 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,209.53 Bn | 1,178.12 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 625.18 Bn | 543.70 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 510.63 Bn | 483.79 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 365.88 Bn | 320.31 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 293.11 Bn | 257.51 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 261.69 Bn | 235.45 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 237.29 Bn | 192.69 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 194.23 Bn | 168.34 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 171.73 Bn | 118.68 Bn | 10.94 Bn | -0.04 |
| 10 | Alzamend Neuro | 6.23 Mn | -9.24 Mn | - | 0.67 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 0.67 |
| Apr 30, 2026 | -0.86 |
| Jan 31, 2026 | -0.58 |
| Oct 31, 2025 | -0.30 |
| Jul 31, 2025 | -1.28 |
| Apr 30, 2025 | -3.64 |
| Jan 31, 2025 | -1.75 |
| Oct 31, 2024 | -3.61 |
| Jul 31, 2024 | -11.27 |
| Apr 30, 2024 | -11.33 |
| Jan 31, 2024 | -33.97 |
| Oct 31, 2023 | -39.85 |
| Jul 31, 2023 | -48.38 |
| Apr 30, 2023 | -45.76 |
| Jan 31, 2023 | -74.49 |
| Oct 31, 2022 | -43.07 |
| Jul 31, 2022 | -42.06 |
| Apr 30, 2022 | -58.63 |
| Jan 31, 2022 | -36.88 |
| Oct 31, 2021 | -52.00 |
API Access
Alzamend Neuro EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();